Skip to main content
    O

    Oscar Health Inc (OSCR)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NYSE

    $31.33
    +0.28 (+0.90%)

    Market Cap: $9.65B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Oscar Health Inc (OSCR) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    Oscar Health reported revenue of $11.70B for the fiscal year ended Dec 31, 2025, up 27.5% from the year before. That year, net income was -$442.90M with a net margin of -3.8%, operating cash flow was $1.09B and free cash flow was $1.06B. The quarter ended Sep 30, 2026 had revenue of $5.14B and net income of $167.30M.

    Revenue and Margins

    The operating margin was -3.4% in the fiscal year ended Dec 2025. Over the 6 years to Dec 2025, revenue grew from $488.19M, a compound annual rate of 69.8%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$11.70B+27.5%100.0%-3.4%-3.8%
    Dec 2024$9.18B+56.5%100.0%0.6%0.3%
    Dec 2023$5.86B+47.9%100.0%-4.0%-4.6%
    Dec 2022$3.96B+115.6%17.2%-14.9%-15.4%
    Dec 2021$1.84B+297.3%11.7%-29.6%-31.1%
    Dec 2020$462.80M-5.2%33.2%-86.9%-87.9%
    Dec 2019$488.19MN/A16.4%-53.1%-53.5%
    Annual, fiscal years ended Dec 2019 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the company posted a net loss after a profit the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Revenue$11.70B$9.18B$5.86B$3.96B$1.84B$462.80M$488.19M
    Cost of revenue$0$0$0$3.28B$1.62B$309.35M$408.26M
    Gross profit$11.70B$9.18B$5.86B$682.84M$214.72M$153.45M$79.93M
    Operating income-$396.36M$57.27M-$235.62M-$589.87M-$544.48M-$402.27M-$259.39M
    Net income-$442.90M$26.12M-$270.59M-$609.55M-$571.43M-$406.82M-$261.18M
    EBITDAN/A$63.21MN/A-$568.98M-$522.72M-$388.07M-$259.14M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$5.14B$4.88B$4.65B$2.81B$2.99B$2.86B$3.05B$2.39B$2.42B$2.22B$2.14B$1.43B
    Gross profit$906.45M$1.09B$1.42B$10.20B$399.65M$310.97M$786.61M$5.66B$2.42B$510.62M$587.53M$3.78B
    Operating income$178.02M$388.63M$704.09M-$333.75M-$129.25M-$230.48M$297.12M-$147.73M-$48.37M$67.81M$185.56M-$145.48M
    Net income$167.30M$361.83M$679.02M-$352.43M-$137.48M-$228.49M$275.51M-$153.28M-$54.39M$56.31M$177.48M-$149.84M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded long-term debt of $430.10M by $2.34B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Total assets$6.33B$4.84B$3.60B$4.53B$3.32B$2.27B$1.35B
    Current assets$4.61B$2.85B$3.06B$4.12B$2.31B$1.87B$725.59M
    Cash and equivalents$2.77B$1.53B$1.87B$1.56B$1.10B$826.33M$336.64M
    Total liabilities$5.34B$3.82B$2.80B$3.63B$1.93B$1.82B$494.24M
    Long-term debt$430.10M$299.56M$298.78M$298.00M$0$142.49MN/A
    Shareholder equity$977.65M$1.01B$803.97M$890.38M$1.39B-$1.30B$852.68M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$10.01B$11.23B$9.29B$6.33B$5.75B$6.38B$5.84B$4.84B$4.48B$5.01B$4.42B$3.60B
    Total liabilities$7.78B$9.17B$7.62B$5.34B$4.72B$5.22B$4.51B$3.82B$3.32B$3.87B$3.38B$2.80B
    Cash and equivalents$4.47B$4.08B$4.81B$2.77B$2.15B$2.60B$2.24B$1.53B$1.21B$2.27B$2.23B$1.87B
    Shareholder equity$2.22B$2.05B$1.66B$977.65M$1.02B$1.16B$1.33B$1.01B$1.16B$1.14B$1.03B$803.97M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 97.2% of operating cash flow.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Operating cash flow$1.09B$978.19M-$272.16M$380.35M-$181.75M$222.73M-$165.37M
    Capital expenditures$36.37M$27.90M$25.58M$29.01M$25.89M$14.02M$26.00M
    Free cash flow$1.06B$950.30M-$297.74M$351.34M-$207.63M$208.71M-$191.37M
    Share repurchasesN/AN/AN/AN/A$9.45M$0$2.99M
    Investing cash flow-$241.06M-$1.39B$577.19M-$226.52M-$774.51M-$344.71M$150.51M
    Financing cash flow$399.21M$68.39M$6.45M$301.11M$1.24B$611.71M-$2.12M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$1.20B$2.09B$2.62B$671.90M-$964.66M$509.07M$878.54M$346.82M-$500.14M$497.15M$634.36M$296.87M
    Capital expenditures$11.31M$11.76M$8.79M$9.06M$9.01M$9.28M$9.03M$6.82M$7.57M$7.56M$5.95M$6.10M
    Free cash flow-$1.21B$2.08B$2.61B$662.84M-$973.66M$499.79M$869.52M$340.00M-$507.71M$489.59M$628.41M$290.77M
    Last 12 quarters

    Frequently Asked Questions About OSCR

    What is Oscar Health's annual revenue?

    Oscar Health reported revenue of $11.70B for the fiscal year ended Dec 31, 2025.

    How fast is Oscar Health's revenue growing?

    Revenue was up 27.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 43.5%.

    Is Oscar Health profitable?

    No. Oscar Health reported net income of -$442.90M for the fiscal year ended Dec 31, 2025, with a net margin of -3.8%.

    How much free cash flow does OSCR generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $1.09B minus capital expenditures of $36.37M produced free cash flow of $1.06B.

    How much debt does Oscar Health have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $430.10M and cash and equivalents of $2.77B.